Biomemory

Biomemory provides biodigital data storage

Founded 2021 France

France 80 employees Series A Total: $23.00M Biotechnology, Data Analytics

General Information

Company Name Biomemory

Founded Year 2021

Location

France

Employees 80

Industries Biotechnology, Data Analytics

Funding Stage Series A

Business Model B2B, D2C, B2B2B

Revenue Model Product Sales, Service Fee, Licensing

Hiring 4 roles posted in the month to 19 Oct 2026

Offices as of Oct 2026

Paris, France

Social

BounceWatch is an independent company data service, not affiliated with Biomemory. To contact Biomemory, visit biomemory.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biomemory compare?

A PDF of Biomemory and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biomemory soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Program Acceptance Oct 16, 2026

Biomemory has been selected for the French Tech 2030 Cohort of 2026, an initiative organized by La French Tech, strengthening France's technological sovereignty.

Product Launch Oct 15, 2026

Biomemory officially launched its first commercial product, DNA Shield, a major step forward in bringing Molecular IT to market.

Award Received Oct 14, 2026

Biomemory was named one of LinkedIn's Top Startups in France for 2026, recognizing its impact, team growth, and ability to attract top talent.

Actively Hiring Oct 12, 2026

Hiring for 4 positions in the last 30 days.

Market Expansion Oct 12, 2026

Biomemory is expanding by opening the North American market, which is anticipated to become its largest globally.

Event Participation Oct 06, 2026

Biomemory will be participating in Scality Day 2026 in Paris on October 8, with Vincent F. from Biomemory speaking on "Can Sovereignty Be Molecular?".

+2 more signals in last 30 days

Get alerts when Biomemory shows new signals

AI Insight

Bounce Watch AI

2 months ago

Biomemory is actively solidifying its market position and deep-tech leadership, evidenced by a senior executive presenting on DNA data storage standards at a major industry conference in July 2026. This strategic engagement, alongside recent hiring and a significant website refresh, suggests the company is preparing for further commercial expansion and product maturation following its Series A funding.

Signal Types

Industry Engagement Hiring Product Update

Strategic Labels

Industry Leadership Market Positioning Operational Scaling

Next Move: Expansion

Impact: 8/10

Ideal For: Deep-Tech & Enterprise Storage Investors — Growth Stage

About Biomemory

Biomemory is a pioneering biotechnology and data analytics company based in France, established in 2021. The company's core innovation lies in its biodigital data storage solutions tailored to large enterprises and governmental administrations. Through advanced molecular engineering, Biomemory creates exabyte rackable appliances that offer both cost-effectiveness and energy efficiency for Data Centers.

Apart from data storage, Biomemory is innovating in DNA-based anti-counterfeiting systems, aligning with sustainability by maintaining a minimal ecological footprint. This dual focus on data storage and security positions the company uniquely in the market.

In its latest funding round, Biomemory secured a $18.00M Series A investment on 01 December 2024, with backing from notable investors such as Bpifrance, Crédit Mutuel Innovation, and Paris Business Angels. This substantial investment underscores investor confidence in Biomemory's technology and its potential for broad market impact.

Business keywords: Biodigital Data Storage, Enterprise Data Storage, Molecular Engineering, Data Center Solutions, Cost-effective Solutions, Energy-efficient Solutions, Exabyte-scale Appliances, DNA Data Storage, Molecular Storage, Molecular Computing, Anti-counterfeiting Systems, Ecological Impact Minimization, Deep-tech

Services & Products

DNA Data Storage solutions

Cybersecurity tailored for data centers

IT-friendly DNA storage and biosecure solutions

Long-term data retention and readability support

Target Customers

Data Centers Enterprise-level IT environments Organizations with high-security and data preservation needs Companies seeking scalable, sustainable storage options

Funding Rounds & Investors (7)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$18.00M	7	Bpifrance, Crédit Mutuel Innovation +5	01 Dec 2024
Support Program	Undisclosed	1	CDL-Paris	01 Sep 2024
Support Program	Undisclosed	1	CDL-Paris	01 Sep 2023
Seed	€5.00M	3	eureKARE, Paris Business Angels +1	01 Nov 2022
Support Program	Undisclosed	1	CNRS Innovation	01 Dec 2021
Support Program	Undisclosed	1	AGORANOV	01 Sep 2021
Spinout	Undisclosed	4	University Ventures, CNRS Innovation +2	01 Jun 2021

Latest News

View All

Biomemory’s DNA Shield stores critical data in synthetic DNA — beyond the reach of cyberattacks

TechRadar Oct 17, 2026

Biomemory lance DNA Shield

L'Informaticien Oct 16, 2026

Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform

Dark Reading Oct 16, 2026

Biomemory Alternatives & Competitors

Biomemory vs

CATALOG United States

DNA Computing Company

Series B

14 employees

Analytics, Biotechnology

Compare Biomemory vs CATALOG

FAQ About Biomemory

Biomemory provides biodigital data storage

Biomemory was founded in 2021.

Biomemory is headquartered in France. As of Oct 2026, it also has offices in Paris, France.

Biomemory operates in Biotechnology and Data Analytics. Its work centres on Biodigital Data Storage, Enterprise Data Storage, Molecular Engineering and Data Center Solutions. Its customers include Data Centers, Enterprise-level IT environments and Organizations with high-security and data preservation needs.

Biomemory has a B2B, D2C and B2B2B business model. Its revenue comes from Product Sales, Service Fee and Licensing.

Biomemory has approximately 80 employees.

Biomemory has completed 7 funding rounds, raising a total of $23.00M. The latest funding stage is Series A.

Biomemory offers: DNA Data Storage solutions, Cybersecurity tailored for data centers, IT-friendly DNA storage and biosecure solutions, Long-term data retention and readability support.

Top alternatives and competitors to Biomemory include CATALOG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Biomemory and CATALOG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biomemory, https://bouncewatch.com/company/biomemory, updated 15 October 2026. When citing, please name BounceWatch and link this page.